Agilent Technologies (A) Cash from Financing Activities (2009 - 2026)
Agilent Technologies (A) posted quarterly Cash from Financing Activities of -$144.0 million for Q2 2026, down 24.14% YoY from -$189.8 million in Q2 2025, and up 35.14% sequentially from -$222.0 million in Q1 2026.
Agilent Technologies (A) Cash from Financing Activities (2009 - 2026) Analysis & Trends
Agilent Technologies has disclosed Cash from Financing Activities across 18 years of filings, most recently posting -$144.0 million for Q2 2026.
- In Q2 2026, Cash from Financing Activities fell 24.14% year-over-year to -$144.0 million; the TTM figure through Apr 2026 stood at -$785.0 million (down 51.84% YoY), while the FY2025 annual figure was -$715.0 million, up 4.92% from the prior year.
- Cash from Financing Activities advanced to -$144.0 million in Q2 2026, from -$222.0 million in the prior quarter.
- Over the last five years, Cash from Financing Activities for A reached as high as $25.0 million in Q4 2024 and fell as low as -$546.0 million in Q1 2022.
- The 5-year median for Cash from Financing Activities is -$220.5 million (2025), against an average of -$229.7 million.
- The widest YoY moves for Cash from Financing Activities: up 112.44% in 2024, down 1311.76% in 2024.
- A 5-year view of Cash from Financing Activities shows it stood at -$341.0 million in 2022, then jumped by 41.06% to -$201.0 million in 2023, then soared by 112.44% to $25.0 million in 2024, then sank by 900.0% to -$200.0 million in 2025, then climbed by 28.0% to -$144.0 million in 2026.
- According to Business Quant data, Cash from Financing Activities over the past three periods registered -$144.0 million, -$222.0 million, and -$200.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | -213.00 Mn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 1.09 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 46.00 Mn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | -211.43 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 3.76 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | -144.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | -433.00 Mn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | -251.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | -114.33 Mn |
| 10 | Quest Diagnostics | 23.76 Bn | 23.67 Bn | 942.00 Mn | -152.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -144.00 Mn |
| Apr 30, 2026 | -144.00 Mn |
| Jan 31, 2026 | -222.00 Mn |
| Jan 31, 2026 | -222.00 Mn |
| Oct 31, 2025 | -200.00 Mn |
| Oct 31, 2025 | -200.00 Mn |
| Jul 31, 2025 | -219.00 Mn |
| Jul 31, 2025 | -219.00 Mn |
| Apr 30, 2025 | -116.00 Mn |
| Apr 30, 2025 | -116.00 Mn |
| Jan 31, 2025 | -180.00 Mn |
| Jan 31, 2025 | -180.00 Mn |
| Oct 31, 2024 | 25.00 Mn |
| Oct 31, 2024 | 25.00 Mn |
| Jul 31, 2024 | -246.00 Mn |
| Jul 31, 2024 | -246.00 Mn |
| Apr 30, 2024 | -291.00 Mn |
| Apr 30, 2024 | -291.00 Mn |
| Jan 31, 2024 | -240.00 Mn |
| Jan 31, 2024 | -240.00 Mn |